Go back and listen to the Earnings conference call (webcast)
On 7 November 2024, we held a conference call to present our results for the nine first months of 2024.
On 6 November 2024, we announced our financial results for the nine first months of 2024.
Download financial workbook (xlsx)
Investor presentation (ipaper)
Go to the conference call webcast
On 8 August 2024, we held a conference call to present our results for the six first months of 2024.
On 7 August 2024, we announced our financial results for the six first months of 2024.
Investor presentation (iPaper)
On 3 May 2024, we held a conference call to present our results for the three first months of 2024.
We announced our financial results for the three first months of 2024.
Novo Nordisk A/S announced financial results for the full year of 2023:
Novo Nordisk A/S hosted a R&D investor call in relation to the annual American Heart Association (AHA) conference. This year the conference is hosted in Philadelphia, US.
Presentation (Webcast)
Presentation (pdf)
Novo Nordisk A/S hosted a R&D investor call in relation to the annual ADA conference. This year the conference is hosted in San Diego, CA.
Full-year 2022 financial results were published 01 February 2023, 7:30 CET:
In connection with ADA 82nd Scientific Sessions Novo Nordisk A/S will host an investor event.